Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

David Simpson, MBChB, FRACP, FRCPA, Henry Chan, MBChB

Blood (2018) 132 (Supplement 1): 3306.

https://doi.org/10.1182/blood-2018-99-110891

Published: 2018

Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD

Blood (2017) 130 (Supplement 1): 3695.

https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695

Published: 2017

Journal Articles

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

James N. Huang, MD, Ri Liesner, Chioma Akenezi, BSc, PgDip, Steven K. Austin, BMedSci, MBBS, Kaan Kavakli, MD

Blood (2017) 130 (Supplement 1): 3736.

https://doi.org/10.1182/blood.V130.Suppl_1.3736.3736

Published: 2017

Journal Articles

Thromboelastography to Detect Hypercoagulability in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

Richard Har Ko, MD MHS, MS, Richard Sposto, PhD, Fariba Goodarzian, Roxana Carmona, IMG, Siobhan Vasquez, BA, Guy Young, MD

Blood (2015) 126 (23): 1118.

https://doi.org/10.1182/blood.V126.23.1118.1118

Published: 2015

Journal Articles

Complications of Central Venous Therapy in Children with Hemophilia in Poland

Pawel Laguna, MD PhD, Anna Klukowska, Katarzyna Pawelec, MD PhD, Michal Matysiak, MD PhD

Blood (2014) 124 (21): 5071.

https://doi.org/10.1182/blood.V124.21.5071.5071

Published: 2014

Journal Articles

A Case Series Evaluating the Use of a Von Willebrand Factor/Factor VIII Concentrate (Wilate®) for Immune Tolerance Induction (ITI) in Children with Severe Factor VIII Deficiency

Mark J. Belletrutti, MD MSc, Roxanne Seiferman-Nelson, RN, Bonny Granfield, RN, BScN

Blood (2014) 124 (21): 5050.

https://doi.org/10.1182/blood.V124.21.5050.5050

Published: 2014

Journal Articles

Thrombin Generation Assay and by-Passing Therapies in Patients with Inhibitors,

Kaan Kavakli, MD, Yilmaz Ay, MD, Deniz Yilmaz Karapinar, MD, Can Balkan, MD

Blood (2011) 118 (21): 3322.

https://doi.org/10.1182/blood.V118.21.3322.3322

Published: 2011

Journal Articles

Barth Syndrome and Severe Chronic Neutropenia.

Shannon Collins, BS, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Lan Phan, BA, David C. Dale, MD

Blood (2010) 116 (21): 3787.

https://doi.org/10.1182/blood.V116.21.3787.3787

Published: 2010

Journal Articles

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

Leonard A. Valentino, MD, FAAP, David L. Cooper, MD, MBA

Blood (2009) 114 (22): 1304.

https://doi.org/10.1182/blood.V114.22.1304.1304

Published: 2009

Journal Articles

New Early Prophylaxis Regimen That Avoids Immunological Danger Signals Can Reduce Factor Eight (FVIII) Inhibitor Development Independent From Product Type Used.

Guenter K.H. Auerswald, MD, Christoph Bidlingmaier, Werner Engl, Heidi Chehadeh, Birgit M Reipert, PhD, Karin Kurnik, MD

Blood (2009) 114 (22): 221.

https://doi.org/10.1182/blood.V114.22.221.221

Published: 2009

Journal Articles

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Paulette Bryant, MD, Richard Parmley, MD, Christine Bolen, MD, Theresa Sunderland, MD, Robert Johnson, MD, Jennifer Weisner, PNP, Karen Nishioka, BSN, Karen Roberts, RN, Richard Towell, RN, Jodi P. Strong, MBA, Evelyn Lockhart, MD, Mark Mogul, MD

Blood (2008) 112 (11): 4067.

https://doi.org/10.1182/blood.V112.11.4067.4067

Published: 2008

Journal Articles

The Effects of 24 Hour Continuous Deferoxamine Intensification on Serum Creatinine.

Dima El-Sharkawi, Bernard Davis, John Porter

Blood (2008) 112 (11): 1851.

https://doi.org/10.1182/blood.V112.11.1851.1851

Published: 2008

Journal Articles

Prophylactic Use of rFVIIa in a Young Hemophilia A Patient with Factor VIII Inhibitor.

Annie Borel-Derlon, MD, PhD, Mounia Slaoui, MD, Philippe Gautier, MD, Patricia Guillon

Blood (2005) 106 (11): 4068.

https://doi.org/10.1182/blood.V106.11.4068.4068

Published: 2005

Journal Articles

Interval Hemin Therapy: Efficacy in Reducing Hospitalizations for Acute Attacks of Acute Intermittent Porphyria.

Rene Rothstein-Rubin, MD

Blood (2005) 106 (11): 3771.

https://doi.org/10.1182/blood.V106.11.3771.3771

Published: 2005

Journal Articles

Quantitiative Analysis of Roughness of Catheters by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM).

Anthony Chan, MBBS, Nagina Parmar, PhD, Anusha Jega, MD, Christopher Yip, PhD, Forough Farrokhyar, PhD, Mark J. Walton, MD

Blood (2005) 106 (11): 3218.

https://doi.org/10.1182/blood.V106.11.3218.3218

Published: 2005

Journal Articles

A Case Report of Prophylactic Hemin Treatments in the Management of Patients with Life-Threatening Attacks of Acute Intermittent Porphyria.

Richard E. Mills, MD

Blood (2005) 106 (11): 3757.

https://doi.org/10.1182/blood.V106.11.3757.3757

Published: 2005

Journal Articles

Long-Term Venous Access Catheters and Infections in Patients with Severe Hemophilia.

Janet A. Harrison, Jerry S. Powell, M.D.

Blood (2004) 104 (11): 4117.

https://doi.org/10.1182/blood.V104.11.4117.4117

Published: 2004

NARROW

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

Thromboelastography to Detect Hypercoagulability in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

Complications of Central Venous Therapy in Children with Hemophilia in Poland

A Case Series Evaluating the Use of a Von Willebrand Factor/Factor VIII Concentrate (Wilate®) for Immune Tolerance Induction (ITI) in Children with Severe Factor VIII Deficiency

Thrombin Generation Assay and by-Passing Therapies in Patients with Inhibitors,

Barth Syndrome and Severe Chronic Neutropenia.

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

New Early Prophylaxis Regimen That Avoids Immunological Danger Signals Can Reduce Factor Eight (FVIII) Inhibitor Development Independent From Product Type Used.

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

The Effects of 24 Hour Continuous Deferoxamine Intensification on Serum Creatinine.

Prophylactic Use of rFVIIa in a Young Hemophilia A Patient with Factor VIII Inhibitor.

Interval Hemin Therapy: Efficacy in Reducing Hospitalizations for Acute Attacks of Acute Intermittent Porphyria.

Quantitiative Analysis of Roughness of Catheters by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM).

A Case Report of Prophylactic Hemin Treatments in the Management of Patients with Life-Threatening Attacks of Acute Intermittent Porphyria.

Long-Term Venous Access Catheters and Infections in Patients with Severe Hemophilia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only